Gene Delivery Technologies Market Size Worth $7.9 Billion By 2028: Grand View Research, Inc.
SAN FRANCISCO, Feb. 9, 2021 /PRNewswire/ -- The global gene delivery technologies market size is expected to reach USD 7.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.1% from 2021 to 2028. Technological advancements in viral vectors, a growing pipeline of advanced therapies, and a rising number of regulatory approvals for advance therapy products are some key driving forces of the market.
Key suggestions from the report:
- The wide implementation of biological gene delivery technologies in clinical usage owing to their high efficiency and specificity has resulted in the segment's largest revenue share in 2020
- Gene therapy development is the key revenue-generating application in the 2020 market owing to constantly expanding pipeline programs of therapies against life-threatening conditions coupled with the recent success of CAR-T therapies
- The recent pandemic of SARS-CoV-2 has also resulted in substantial global investments in R&D of viral vector-based vaccine to combat the virus, resulting in lucrative growth of this segment
- The ex vivo method accounted for the major revenue share owing to its advantages such as high transduction efficiency and less immunogenic responses
- However, both in vivo and ex vivo have shown clinical success in the treatment of chronic conditions, thus both segments are expected to witness lucrative growth in the coming years
- Given the high number of biotech companies and a favorable regulatory environment in the U.S.; North America dominated the global market in terms of revenue
- On the other hand, Asia Pacific is projected to grow at the fastest pace during the forecast period
- Constantly evolving CDMO and viral vector manufacturing landscapes through plant expansions and new sites being built across the Asian countries is spurring the adoption of vectors in this region
- The key players are engaged in collaboration with therapy developers to support their product development process
Read 150 page research report with ToC on "Gene Delivery Technologies Market Size, Share & Trends Analysis Report By Mode (AAV, Lentivirus, Retrovirus), By Application (Gene Therapy, Cell Therapy), By Method (Ex-vivo, In-vivo), By Region, And Segment Forecasts, 2021 - 2028" at: https://www.grandviewresearch.com/industry-analysis/gene-delivery-technologies-market
Several novel tools are being introduced for genetic alterations that have facilitated the scientific community to delineate the disease intricacies at the genomic level, leading to the emergence of novel gene delivery approaches. Furthermore, ongoing research to develop clinically relevant vectors including viral and non-viral vectors to combat chronic illnesses such as cancer, Alzheimer's, and others through advanced therapies is spurring the market revenue.
An increase in investment and financing in the space to support the research, development, and manufacturing of various modes of gene transfer further accelerates the revenue growth. Currently, around 70% of gene and cell therapy programs are based on viral vectors leading to organic revenue growth for biological delivery technologies. The operating players are investing significantly to scale up their viral vector manufacturing capability and meet the growing demand.
Considering growing opportunities in physio-chemical gene delivery approaches, key players are making focused efforts to boost their business presence. For instance, nanoparticles have proven their efficiency as promising vehicles for clinical usage owing to their tunable morphology, and biological behaviors. Such ongoing developments in the space are anticipated to accelerate revenue growth in this market in the coming years.
Grand View Research has segmented the global gene delivery technologies market on the basis of mode, application, method, and region:
Gene Delivery Technologies Mode Outlook (Revenue, USD Million, 2017 - 2028)
- Biological
- Adenovirus
- Retrovirus
- AAV
- Lentivirus
- Other viruses
- Non-viral
- Chemical
- Physical
- Gene Delivery Technologies Application Outlook (Revenue, USD Million, 2017 - 2028)
- Gene Therapy
- Cell Therapy
- Vaccines
- Research
- Gene Delivery Technologies Method Outlook (Revenue, USD Million, 2017 - 2028)
- Ex vivo
- In vivo
- In vitro
- Gene Delivery Technologies Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Middle East & Africa (MEA)
- South Africa
- South Arabia
List of Key Players in Gene Delivery Technologies Market
- Thermo Fisher Scientific, Inc.
- QIAGEN
- Horizon Discovery Group Co.
- OriGene Technologies, Inc.
- Oxford Biomedica
- SignaGen Laboratories
- Vectalys
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- System Biosciences llc
- Promega Corporation
- Hoffmann-La Roche AG
- Sirion-Biotech GmbH
- Catalent Inc.
Find more research reports on Biotechnology Industry, by Grand View Research:
- Gene Therapy Market – The global gene therapy market size was valued at USD 2.26 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 20.4% from 2021 to 2028.
- Viral Vectors & Plasmid DNA Manufacturing Market – The global viral vectors & plasmid DNA manufacturing market size was estimated at USD 368.3 million in 2019 and is projected to expand at a CAGR of 14.52% during the forecast period.
- Cell Therapy Market – The global cell therapy market size was valued at USD 5.8 billion in 2019 and is projected to witness a CAGR of 5.4% during the forecast period.
Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Logo - https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
Share this article